Skip to content
healthcare.dev

AMLODIPINE BESYLATE

NDC 82009-028, AMLODIPINE BESYLATE, tablet, from Quallent Pharmaceuticals Health LLC.

Product NDC
82009-028
Status
Listed
Labeler
Quallent Pharmaceuticals Health LLC
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA077073
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/82009-028 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • AMLODIPINE BESYLATE10 mg/1

Pharmacologic classes

Calcium Channel Antagonists [MoA]; Calcium Channel Blocker [EPC]; Cytochrome P450 3A Inhibitors [MoA]; Dihydropyridine Calcium Channel Blocker [EPC]; Dihydropyridines [CS]

Package NDCNDC-11Package
82009-028-10820090028101000 TABLET in 1 BOTTLE (82009-028-10)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/c262dedb-1d13-4447-9355-f11e1dbbfb4d
  • NADAC price for package 82009002810

    GET /v1/drugs/nadac/82009002810

Use it

Look up 82009-028 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/82009-028 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 82009-028. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.